{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:18:19Z","timestamp":1790813899561,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006518","name":"University of Nebraska Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","ajkd.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1053\/j.ajkd.2024.07.018","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T09:59:19Z","timestamp":1729072759000},"page":"364-374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Biomarkers of Rejection in Kidney Transplantation"],"prefix":"10.1053","volume":"85","author":[{"given":"Scott G.","family":"Westphal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1776-3680","authenticated-orcid":false,"given":"Roslyn B.","family":"Mannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2024.07.018_bib1","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1111\/ajt.16463","article-title":"Long-term kidney transplant graft survival\u2014making progress when most needed","volume":"21","author":"Poggio","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2024.07.018_bib2","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/ajt.16907","article-title":"Effectiveness of T cell-mediated rejection therapy: a systematic review and meta-analysis","volume":"22","author":"Ho","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2024.07.018_bib3","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/ajt.14933","article-title":"Subclinical inflammation phenotypes and long-term outcomes after pediatric kidney transplantation","volume":"18","author":"Seifert","year":"2018","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2024.07.018_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.12945","article-title":"Kidney allograft surveillance biopsy practices across US transplant centers: a UNOS survey","volume":"31","author":"Mehta","year":"2017","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2024.07.018_bib5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1399-0012.2005.00377.x","article-title":"Reproducibility of the Banff classification in subclinical kidney transplant rejection","volume":"19","author":"Veronese","year":"2005","journal-title":"Clin Transplant"},{"issue":"10","key":"10.1053\/j.ajkd.2024.07.018_bib6","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1111\/j.1600-6143.2007.01924.x","article-title":"SWOT analysis of Banff: strengths, weakness, opportunities and threats of the international Banff consensus process and classification system for renal allograft pathology","volume":"7","author":"Mengel","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2024.07.018_bib7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1681\/ASN.2016080858","article-title":"Moving biomarkers toward clinical implementation in kidney transplantation","volume":"2","author":"Menon","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2024.07.018_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MOT.0000000000000941","article-title":"Emerging biomarkers in kidney transplantation and challenge of clinical implementation","volume":"27","author":"Westphal","year":"2022","journal-title":"Curr Opin Organ Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2024.07.018_bib9","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000003064","article-title":"A\u00a0practical guide to the clinical implementation of biomarkers for subclinical rejection following kidney transplantation","volume":"104","author":"Naesens","year":"2020","journal-title":"Transplantation"},{"key":"10.1053\/j.ajkd.2024.07.018_bib10","first-page":"591","article-title":"Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury","volume":"17","author":"Oellerich","year":"2021","journal-title":"Nat Rev"},{"key":"10.1053\/j.ajkd.2024.07.018_bib11","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1681\/ASN.2016091034","article-title":"Cell-free DNA and active rejection in kidney allografts","volume":"28","author":"Bloom","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2024.07.018_bib12","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1097\/TP.0000000000002665","article-title":"Analytical validation of a single-nucleotide polymorphism-based donor-derived cell-free DNA assay for detecting rejection in kidney transplant patients","volume":"103","author":"Altug","year":"2019","journal-title":"Transplantation"},{"key":"10.1053\/j.ajkd.2024.07.018_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005629","article-title":"Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype","volume":"13","author":"Sharon","year":"2017","journal-title":"PLoS Comput Biol"},{"issue":"12","key":"10.1053\/j.ajkd.2024.07.018_bib14","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1373\/clinchem.2013.210328","article-title":"Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury","volume":"59","author":"Beck","year":"2013","journal-title":"Clin Chem"},{"key":"10.1053\/j.ajkd.2024.07.018_bib15","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/ajt.15289","article-title":"Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipient","volume":"19","author":"Huang","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2024.07.018_bib16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.kint.2021.11.034","article-title":"Clinical outcomes from the Assessing donor-derived cell-free DNA Monitoring Insights of Kidney Allografts With Longitudinal Surveillance (ADMIRAL) Study","volume":"101","author":"Bu","year":"2022","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2024.07.018_bib17","first-page":"19","article-title":"Optimizing detection of kidney transplant injury by assessment of donor-derived cell-free DNA via massively multiplex PCR","volume":"8","author":"Sigdel","year":"2019","journal-title":"J\u00a0Clin Med"},{"issue":"2","key":"10.1053\/j.ajkd.2024.07.018_bib18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1681\/ASN.2021091191","article-title":"The Trifecta Study: comparing plasma levels of donor-derived cell-free DNA with the molecular phenotype of kidney transplant biopsies","volume":"33","author":"Halloran","year":"2022","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2024.07.018_bib19","author":"Bixler"},{"key":"10.1053\/j.ajkd.2024.07.018_bib20","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.2215\/CJN.05530421","article-title":"Combining blood gene expression and cellfree DNA to diagnose subclinical rejection in kidney transplant recipients","volume":"16","author":"Park","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2024.07.018_bib21","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1111\/ajt.15416","article-title":"Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: results from a prospective observational study","volume":"19","author":"Oellerich","year":"2019","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1053\/j.ajkd.2024.07.018_bib22","doi-asserted-by":"crossref","first-page":"e778","DOI":"10.1097\/TXD.0000000000001237","article-title":"Absolute or relative quantification of donor-derived cell-free DNA in kidney transplant recipients: case series","volume":"7","author":"Osmanodja","year":"2021","journal-title":"Transplant Direct"},{"key":"10.1053\/j.ajkd.2024.07.018_bib23","first-page":"2439","article-title":"Using both the fraction and quantity of donor-derived cell-free DNA to detect kidney allograft rejection","volume":"32","author":"Bunnapradist","year":"2021","journal-title":"J\u00a0Am Kidney Soc"},{"key":"10.1053\/j.ajkd.2024.07.018_bib24","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/ajt.15142","article-title":"Diagnostic application of kidney allograft-derived absolute cell-free DNA levels during transplant dysfunction","volume":"19","author":"Whitlam","year":"2019","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1053\/j.ajkd.2024.07.018_bib25","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1097\/TP.0000000000004212","article-title":"Combining donor-derived cell-free DNA fraction and quantity to detect kidney transplant rejection using molecular diagnoses and histology as confirmation","volume":"106","author":"Halloran","year":"2022","journal-title":"Transplantation"},{"key":"10.1053\/j.ajkd.2024.07.018_bib26","doi-asserted-by":"crossref","first-page":"E5503","DOI":"10.1073\/pnas.1508736112","article-title":"Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer and transplantation assessments","volume":"112","author":"Sun","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1053\/j.ajkd.2024.07.018_bib27","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/clinchem\/hvaa175","article-title":"Time-dependent apparent increase in dd-cfDNA percentage in clinically stable patients between one and five years following kidney transplantation","volume":"66","author":"Schutz","year":"2020","journal-title":"Clin Chem"},{"key":"10.1053\/j.ajkd.2024.07.018_bib28","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.34067\/KID.0003512020","article-title":"Donor-derived cell free DNA: is it all the same?","volume":"1","author":"Melancon","year":"2020","journal-title":"Kidney 360"},{"issue":"3","key":"10.1053\/j.ajkd.2024.07.018_bib29","article-title":"Single center experience comparing two clinically available donor derived cell free DNA tests and review of literature","volume":"6","author":"Lum","year":"2021","journal-title":"Transplant Rep"},{"key":"10.1053\/j.ajkd.2024.07.018_bib30","article-title":"Association between dd-cfDNA levels, de novo donor specific antibodies, and eGFR decline: an analysis of the DART cohort","volume":"35","author":"Sawkinski","year":"2021","journal-title":"Clin Transplant"},{"key":"10.1053\/j.ajkd.2024.07.018_bib31","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/ajt.15197","article-title":"The clinical and pathological significance of borderline T cell-mediated rejection","volume":"19","author":"Nankivell","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2024.07.018_bib32","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1111\/ajt.15822","article-title":"High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury","volume":"20","author":"Stites","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2024.07.018_bib33","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001027","article-title":"Donor-derived cell-free DNA combined with histology improves prediction of estimated glomerular filtration rate over time in kidney transplant recipients compared with histology alone","volume":"6","author":"Huang","year":"2020","journal-title":"Transplant Direct"},{"issue":"3","key":"10.1053\/j.ajkd.2024.07.018_bib34","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/ajt.16883","article-title":"The negative impact of T cell-mediated rejection on renal allograft survival in the modern era","volume":"22","author":"Rampersad","year":"2022","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2024.07.018_bib35","doi-asserted-by":"crossref","first-page":"729","DOI":"10.34067\/KID.0000042021","article-title":"Dynamic response of donor-derived cell-free DNA following treatment of acute rejection in kidney allografts","volume":"2","author":"Wolf-Doty","year":"2021","journal-title":"Kidney360"},{"issue":"5","key":"10.1053\/j.ajkd.2024.07.018_bib36","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/TP.0000000000003838","article-title":"Correlation of donor-derived cell-free DNA with histology and molecular diagnoses of kidney transplant biopsies","volume":"106","author":"Gupta","year":"2022","journal-title":"Transplantation"},{"key":"10.1053\/j.ajkd.2024.07.018_bib37","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14053","article-title":"Prognostic value of the donor-derived cell-free DNA assay in acute renal rejection therapy: a prospective cohort study","volume":"34","author":"Shen","year":"2020","journal-title":"Clin Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2024.07.018_bib38","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1053\/j.ajkd.2024.07.018_bib39","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1111\/ajt.14466","article-title":"Utility of protocol kidney biopsies for de novo donor-specific antibodies","volume":"17","author":"Parajuli","year":"2017","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2024.07.018_bib40","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/TP.0000000000004324","article-title":"Antibody-mediated rejection without detectable donor-specific antibody releases donor-derived cell-free DNA: results from the Trifecta Study","volume":"107","author":"Halloran","year":"2023","journal-title":"Transplantation"},{"key":"10.1053\/j.ajkd.2024.07.018_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-19017-7","article-title":"Combining donor-derived cell-free DNA and donor specific antibody testing as non-invasive biomarkers for rejection in kidney transplantation","volume":"12","author":"Obrisca","year":"2022","journal-title":"Sci Rep"},{"issue":"9","key":"10.1053\/j.ajkd.2024.07.018_bib42","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1097\/TXD.0000000000000821","article-title":"Donor-derived cell-free DNA identifies antibody-mediated rejection in donor specific antibody positive kidney transplant recipients","volume":"4","author":"Jordan","year":"2018","journal-title":"Transplant Direct"},{"issue":"8","key":"10.1053\/j.ajkd.2024.07.018_bib43","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1111\/ajt.17092","article-title":"Molecular diagnosis of ABMR with or without donor-specific antibody in kidney transplant biopsies: differences in timing and intensity but similar mechanisms and outcomes","volume":"22","author":"Halloran","year":"2022","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1053\/j.ajkd.2024.07.018_bib44","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1097\/TP.0000000000005007","article-title":"Elevation of donor-derived cell-free DNA before biopsy-proven rejection in kidney transplant","volume":"108","author":"Bromberg","year":"2024","journal-title":"Transplantation"},{"issue":"8","key":"10.1053\/j.ajkd.2024.07.018_bib45","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1038\/s41591-024-03087-3","article-title":"Cell-free DNA for the detection of kidney allograft rejection","volume":"30","author":"Aubert","year":"2024","journal-title":"Nat Med"},{"key":"10.1053\/j.ajkd.2024.07.018_bib46","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/ajt.15011","article-title":"Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant","volume":"19","author":"Friedewald","year":"2019","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1053\/j.ajkd.2024.07.018_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14987","article-title":"Multiple abnormal peripheral blood gene expression assay results are correlated with subsequent graft loss after kidney transplantation","volume":"37","author":"Heilman","year":"2023","journal-title":"Clin Transplant"},{"issue":"10048","key":"10.1053\/j.ajkd.2024.07.018_bib48","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(16)30826-1","article-title":"Biopsy transcriptome expression profiling to identify kidney transplants at risk of chronic injury: a multicenter, prospective study","volume":"388","author":"O\u2019Connell","year":"2016","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2024.07.018_bib49","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ajt.2023.10.029","article-title":"Inside look: are noninvasive biomarkers up to standard?","volume":"24","author":"Akalin","year":"2024","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1053\/j.ajkd.2024.07.018_bib50","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1681\/ASN.2018111098","article-title":"A\u00a0peripheral blood gene expression signature to diagnose subclinical acute rejection","volume":"30","author":"Zhang","year":"2019","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2024.07.018_bib51","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ajt.2023.09.021","article-title":"Prospective observational study to validate a next-generation sequencing blood RNA signature to predict early kidney transplant rejection","volume":"24","author":"Bestard","year":"2024","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2024.07.018_bib52","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1056\/NEJMoa0912965","article-title":"Gene-expression profiling for rejection surveillance after cardiac transplantation","volume":"362","author":"Pham","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2024.07.018_bib53","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.34067\/KID.0005062021","article-title":"Clinical validation of an immune quiescence gene expression signature in kidney transplantation","volume":"2","author":"Akalin","year":"2021","journal-title":"Kidney360"},{"key":"10.1053\/j.ajkd.2024.07.018_bib54","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ebiom.2019.07.028","article-title":"Development and validation of a peripheral blood mRNA assay for the assessment of antibody-mediated kidney allograft rejection: a multicenter, prospective study","volume":"46","author":"Van Loon","year":"2019","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1053\/j.ajkd.2024.07.018_bib55","article-title":"The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART","volume":"11","author":"Roedder","year":"2014","journal-title":"Study"},{"key":"10.1053\/j.ajkd.2024.07.018_bib56","first-page":"2271","article-title":"Performance and advancement of the kidney solid organ response test","volume":"107","author":"Lee","year":"2023","journal-title":"Transplantation"},{"issue":"2","key":"10.1053\/j.ajkd.2024.07.018_bib57","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/ajt.16179","article-title":"Diagnostic performance of kSORT, a blood-based mRNA assay for noninvasive detection of rejection after kidney transplantation: a retrospective multicenter cohort study","volume":"21","author":"Van Loon","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2024.07.018_bib58","article-title":"Blood gene signature as a biomarker for subclinical kidney allograft rejection: where are we?","author":"Masset","year":"2024","journal-title":"Transplantation"},{"issue":"10","key":"10.1053\/j.ajkd.2024.07.018_bib59","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.2215\/CJN.14010820","article-title":"Urinary cell mRNA profiles predictive of human kidney allograft status","volume":"16","author":"Lubetsky","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2024.07.018_bib60","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/TP.0000000000004017","article-title":"Urinary biomarkers for kidney allograft injury","volume":"106","author":"Jin","year":"2022","journal-title":"Transplantation"},{"issue":"1","key":"10.1053\/j.ajkd.2024.07.018_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pathol.2023.10.004","article-title":"Exosomes and microvesicles in kidney transplantation: the long road from trash to gold","volume":"56","author":"Ramalhete","year":"2024","journal-title":"Pathology"},{"key":"10.1053\/j.ajkd.2024.07.018_bib62","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1681\/ASN.2020060850","article-title":"Discovery and validation of a urinary exosome mRNA signature for the diagnosis of human kidney transplant rejection","volume":"32","author":"El Fekih","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2024.07.018_bib63","article-title":"Development and validation of urinary exosomal microRNA biomarkers for the diagnosis of acute rejection in kidney transplant recipients","volume":"14","author":"Seo","year":"2023","journal-title":"Front Immunol"},{"key":"10.1053\/j.ajkd.2024.07.018_bib64","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1111\/ajt.12426","article-title":"Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury","volume":"13","author":"Hricik","year":"2013","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2024.07.018_bib65","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/MOT.0000000000001135","article-title":"Urine CXCL10 as a biomarker in kidney transplantation","volume":"29","author":"Hirt-Minkowski","year":"2024","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1053\/j.ajkd.2024.07.018_bib66","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/ajt.16336","article-title":"Validity and utility of urinary CXCL10\/Cr immune monitoring in pediatric kidney transplant recipients","volume":"21","author":"Blydt-Hansen","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2024.07.018_bib67","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/tri.13584","article-title":"Longitudinal assessment of the CXCL 10 blood and urine concentration in kidney transplant recipients with BK polyomavirus replication-a retrospective study","volume":"33","author":"Weseslindtner","year":"2020","journal-title":"Transpl Int"},{"key":"10.1053\/j.ajkd.2024.07.018_bib68","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1111\/ajt.15959","article-title":"Development and validation of an optimized integrative model using urinary chemokines for noninvasive diagnosis of acute allograft rejection","volume":"20","author":"Tinel","year":"2020","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2024.07.018_bib69","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1053\/j.ajkd.2023.07.022","article-title":"Automated urinary chemokine assays for noninvasive detection of kidney transplant rejection: a prospective cohort study","volume":"83","author":"Van Loon","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1053\/j.ajkd.2024.07.018_bib70","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1097\/TP.0000000000004554","article-title":"Multicenter validation of a urine CXCL 10 assay for noninvasive monitoring of renal transplants","volume":"107","author":"Ho","year":"2023","journal-title":"Transplantation"},{"key":"10.1053\/j.ajkd.2024.07.018_bib71","first-page":"1456","article-title":"Randomized trial to assess the clinical utility of renal allograft monitoring by urine CXCL10 chemokine","volume":"34","author":"Hirt-Minkowski","year":"2023","journal-title":"J\u00a0Am Kidney Soc"},{"key":"10.1053\/j.ajkd.2024.07.018_bib72","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024908","article-title":"Multicentre randomised controlled trial protocol of urine CXCL 10 monitoring strategy in kidney transplant recipients","volume":"9","author":"Ho","year":"2019","journal-title":"BMJ Open"},{"issue":"2","key":"10.1053\/j.ajkd.2024.07.018_bib73","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1681\/ASN.0000000000000260","article-title":"Prognostic biomarkers in kidney transplantation: a systematic review and critical appraisal","volume":"35","author":"Raynaud","year":"2024","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2024.07.018_bib74","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/ajt.14752","article-title":"Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group meeting report","volume":"18","author":"Tambur","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2024.07.018_bib75","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/ajt.16150","article-title":"Economic analysis of screening for subclinical rejection in kidney transplantation using protocol biopsies and noninvasive biomarkers","volume":"21","author":"Puttarajappa","year":"2021","journal-title":"Am J Transplant"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263862401028X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263862401028X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T05:21:22Z","timestamp":1742534482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027263862401028X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S027263862401028X"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2024.07.018","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers of Rejection in Kidney Transplantation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2024.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. This is a US Government Work. There are no restrictions on its use.","name":"copyright","label":"Copyright"}]}}